329
Participants
Start Date
June 30, 2009
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
AZD3199
Dry powder for inhalation, o.d., 4 weeks
formoterol
Dry powder for inhalation, b.i.d., 4 weeks
Placebo
Dry powder for inhalation, b.i.d., 4 weeks
Research Site, Blagoevgrad
Research Site, Pleven
Research Site, Rousse
Research Site, Sofia
Research Site, Varna
Research Site, Moncton
Research Site, St. John's
Research Site, Truro
Research Site, Greater Sudbury
Research Site, Mississauga
Research Site, Toronto
Research Site, Pointe-Claire
Research Site, Saint Romuald
Research Site, Trois-Rivières
Research Site, Yanagawa
Research Site, Fukuyama
Research Site, Chitose
Research Site, Obihiro
Research Site, Tomakomai
Research Site, Hitachi
Research Site, Naka-gun
Research Site, Sendai
Research Site, Osaka
Research Site, Toyonaka
Research Site, Moriyama
Research Site, Ōtsu
Research Site, Machida
Research Site, Kitakyushu
Research Site, Bialystok
Research Site, Gorzow Wlkp
Research Site, Lodz
Research Site, Lublin
Research Site, Poznan
Research Site, Szczecin
Research Site, Tarnów
Research Site, Moscow
Research Site, Novosibirsk
Research Site, Saint Petersburg
Lead Sponsor
AstraZeneca
INDUSTRY